 | VistaGen Therapeutics, Inc. | |||
| NCM : VTGN || Location: United States | ||||
$4.76+0.06 (+1.28%) |
0.15 M | 4.66 - 4.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.279 M |
| March 15, 2024 | 1.335 M |
| Feb. 29, 2024 | 1.461 M |
| Feb. 15, 2024 | 1.722 M |
| Jan. 31, 2024 | 1.349 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.31 | -0.22 | 28.71% |
| 09/30/2023 | -0.69 | -0.66 | 4.84% |
| 03/31/2023 | -1.53 | -1.75 | -14.38% |
| 12/31/2022 | -2.14 | -1.50 | 29.97% |
| 09/30/2022 | -2.04 | -2.40 | -17.64% |
VTGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 27.025M | Shares Float | 15.254M |
| Short Float | 1.279M | Market Cap | 128.64M |
| Institution ownership | 63.16% | Insider ownership | 0.167% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -2.96 | Forward EPS | -1.96 |